In conclusion, our study supports PTK6 inhibition as a strategy to induce apoptosis of Lapatinib-resistant Her2+ breast tumors by enhancing expression of pro-apoptotic Bim that may be suppressed via multiple mechanisms in breast cancers. Here, ERBB2 is linked to breast neoplasm.